跳至主要内容
临床试验/NCT00033046
NCT00033046Unknown1 期

Safety Evaluation of Cocaine Treatment Medication Modafinil: Interactions With Intravenous Cocaine

National Institute on Drug Abuse (NIDA)2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2001年6月最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
12
试验地点
2
主要终点
pharmacokinetic parmaters at steady state

研究概览

简要总结

The purpose of this study is to evaluate modafinil, a cocaine treatment medication, and its interactions with intravenous (IV) cocaine.

详细描述

Placebo-controlled, escalating dose drug interaction study using a total of 12 cocaine users at a single site. Study duration will include four infusion sessions: 1) screening/baseline; 2) baseline; 3) 400mg/day steady-state modafinil; 4) 800 mg/day steady state modafinil. Infusion session will be 2 days in duration.

研究设计

研究类型
Interventional
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Dependent on cocaine; non-treatment seeking; male or female; DSM-4 criteria for cocaine abuse or dependence; at least 18 years of age but no older than 45 non-pregnant females using adequate birth control; capable of providing written informed consent; able to comply with protocol requirements.

排除标准

  • Additional criteria available during screening at the site

结局指标

主要结局

pharmacokinetic parmaters at steady state

BP, HR

次要结局

未报告次要终点

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验

Evaluation of Modafinil as a Cocaine Treatment... | 临床试验